SIA
BIOTW

SkyView Investment Advisors’s Biotech Acquisition Company Warrant BIOTW Stock Holding History

SkyView Investment Advisors’s Portfolio BIOTW Stock Details BIOTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,591
Closed – – 846
2022
Q4 		$0 Hold
1,591
– – ﹤0.01% 537
2022
Q3 		$0 Hold
1,591
– – ﹤0.01% 596
2022
Q2 		$0 Buy
+1,591
New +$329 ﹤0.01% 652

SkyView Investment Advisors's BIOTW Position: Q1 2023 in Review

SkyView Investment Advisors sold out of Biotech Acquisition Company Warrant (BIOTW) in Q1 2023, closing a stake of 1,591 shares.

SkyView Investment Advisors first reported a position in BIOTW in Q2 2022 and held it in 3 quarters. The position peaked at $0 in Q4 2022. 0 funds tracked by Wall St. Rank hold BIOTW as of Q1 2023.

  • SkyView Investment Advisors reported no remaining Biotech Acquisition Company Warrant position as of Q1 2023 after selling out during the quarter.
  • SkyView Investment Advisors sold 1,591 Biotech Acquisition Company Warrant shares in Q1 2023.
  • SkyView Investment Advisors first reported a position in Biotech Acquisition Company Warrant in Q2 2022 and held it in 3 quarters.
  • SkyView Investment Advisors's Biotech Acquisition Company Warrant position peaked at $0 in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Biotech Acquisition Company Warrant as of Q1 2023.

Based on SkyView Investment Advisors's 13F filing for Q1 2023, filed 18 May 2023.